Management of acne with emesis procedure by using Dhamargava as drug
Phase 2
- Conditions
- Health Condition 1: L700- Acne vulgarisHealth Condition 2: L989- Disorder of the skin and subcutaneous tissue, unspecified
- Registration Number
- CTRI/2024/03/063847
- Lead Sponsor
- Richa Girishchandra Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients of Age group 18 - 34 years of either sex are included.
2.Patients fit for Vamana Krama
3.Patients will be selected with signs and symptoms of Mukhdaushika (Acne Vulgaris) Viz comedones, Papules, Postules and Nodules
Exclusion Criteria
1.Patients contraindicated for Vaman Karma.
2.Pregnant Women and lactating mother
3.Patient suffering from secondary skin disease e.g. psoriasis on face, Vitiligo.
4.Patients with current or past one month use of long-term steroid therapy or any medication.
5.Known patients of psychological disorder, diabetes and hypertension.
6.Patients with evidence of ren al, hepatic and cardiac involvement.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in signs and symptoms of Acne vulgaris <br/ ><br> <br/ ><br>Timepoint: Base line, 15th day, 30th day <br/ ><br>
- Secondary Outcome Measures
Name Time Method Improvement in Global Acne Grading System <br/ ><br> <br/ ><br>Timepoint: Base line, 15th day, 30th day